| Bioactivity | DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C6,15N)HTTPLPVTDT (TFA) is the 13C and 15N labeled isotope of DHATS-PVTIPSAVST-HTTPLPVTDT (TFA)[1]. |
| Sequence | Asp-His-Ala-Thr-Ser-Leu-Pro-Val-Thr-Ile-Pro-Ser-Ala-Val-Ser-Thr-Gly-His-Thr-Thr-Pro-Leu-Pro-Val-Thr-Asp-Thr |
| Shortening | DHATSLPVTIPSAVSTGHTTPLPVTDT |
| Formula | C11013C8H191N2915N2O42.xC2HF3O2 |
| Molar Mass | 2725.89 (free acid) |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Russak, et sl. Impact of deuterium substitution on the pharmacokinetics of pharmaceuticals. Annals of Pharmacotherapy 53.2 (2019): 211-225. |
DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C6,15N)HTTPLPVTDT TFA
CAS: F: C11013C8H191N2915N2O42.xC2HF3O2 W: 2725.89 (free acid)
DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C6,15N)HTTPLPVTDT (TFA) is the 13C and 15N labeled isotope of DHATS-PVTIPSAVST-HTTPL
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.